New drugs.
D000287:Administration, Topical; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001384:Azetidines / Q000627:therapeutic use; D002648:Child; D004358:Drug Therapy; D000069438:Ezetimibe; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D048628:Ketolides / Q000627:therapeutic use; D004364:Pharmaceutical Preparations; D016559:Tacrolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000924:Anticholesteremic Agents; D001384:Azetidines; D007166:Immunosuppressive Agents; D048628:Ketolides; D004364:Pharmaceutical Preparations; C117268:pimecrolimus; D000069438:Ezetimibe; C106791:telithromycin; D016559:Tacrolimus